Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Rimm

Showing results (91-100 of 412) with videos related to

Pageof 42
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancerMalini Harigopal, Aaron J Berger, Robert L Camp, et al.
Oncoimmunology|January 18, 2021
Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapySandra Martinez-Morilla, Jon Zugazagoitia, Pok Fai Wong, et al.
Oncology Research|December 3, 2003
Frequent alterations of Smad signaling in human head and neck squamous cell carcinomas: a tissue microarray analysisWen Xie, Savita Bharathy, David Kim, et al.
Cancer|December 19, 2007
Fine-needle aspiration of follicular adenoma versus parathyroid adenoma: the utility of multispectral imaging in differentiating lesions with subtle cytomorphologic differencesIbrahim Mansoor, Carola Zalles, Farhan Zahid, et al.
Expert Review of Molecular Diagnostics|March 18, 2020
Advances in quantitative immunohistochemistry and their contribution to breast cancerVesal Yaghoobi, Sandra Martinez-Morilla, Yuting Liu, et al.
Human Pathology|July 3, 2025
Tumor infiltrating lymphocytes in breast cancer: A narrative review with focus on analytic validity, clinical validity, and clinical utilityBrian S Finkelman, Huina Zhang, David G Hicks, et al.
Cancer|April 4, 2003
Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptorsIdris Tolgay Ocal, Marisa Dolled-Filhart, Thomas G D'Aquila, et al.
Cancer|June 16, 2004
alphaB-crystallin as a marker of lymph node involvement in breast carcinomaDina Chelouche-Lev, Harriet M Kluger, Aaron J Berger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2014
Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancerJason R Brown, Hallie Wimberly, Donald R Lannin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancerYasmine Nadler, Robert L Camp, Candice Schwartz, et al.
Pageof 42

Showing results (91-100 of 412) with videos related to

Sort By:
Pageof 42
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancerMalini Harigopal, Aaron J Berger, Robert L Camp, et al.
Oncoimmunology|January 18, 2021
Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapySandra Martinez-Morilla, Jon Zugazagoitia, Pok Fai Wong, et al.
Oncology Research|December 3, 2003
Frequent alterations of Smad signaling in human head and neck squamous cell carcinomas: a tissue microarray analysisWen Xie, Savita Bharathy, David Kim, et al.
Cancer|December 19, 2007
Fine-needle aspiration of follicular adenoma versus parathyroid adenoma: the utility of multispectral imaging in differentiating lesions with subtle cytomorphologic differencesIbrahim Mansoor, Carola Zalles, Farhan Zahid, et al.
Expert Review of Molecular Diagnostics|March 18, 2020
Advances in quantitative immunohistochemistry and their contribution to breast cancerVesal Yaghoobi, Sandra Martinez-Morilla, Yuting Liu, et al.
Human Pathology|July 3, 2025
Tumor infiltrating lymphocytes in breast cancer: A narrative review with focus on analytic validity, clinical validity, and clinical utilityBrian S Finkelman, Huina Zhang, David G Hicks, et al.
Cancer|April 4, 2003
Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptorsIdris Tolgay Ocal, Marisa Dolled-Filhart, Thomas G D'Aquila, et al.
Cancer|June 16, 2004
alphaB-crystallin as a marker of lymph node involvement in breast carcinomaDina Chelouche-Lev, Harriet M Kluger, Aaron J Berger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2014
Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancerJason R Brown, Hallie Wimberly, Donald R Lannin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancerYasmine Nadler, Robert L Camp, Candice Schwartz, et al.
Pageof 42